Skip to main content

MARSHALL WACE, LLP

Position in CCCC — C4 Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in CCCC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,060,103
+$651,152 QoQ
Shares Held
227,003
+46.0% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 147 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. CCCC ranks #174 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CCCC

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,060,103 227,003
2026-03-31 $408,951 155,495
2025-12-31 $506,200 265,027
2025-09-30 $235,930 106,275
2024-12-31 $130,201 36,167
2024-09-30 $1,284,870 225,416
2024-03-31 $1,198,081 146,644
2023-12-31 $6,345,294 1,123,061
2023-03-31 $355,561 113,236
2022-06-30 $1,902,537 252,326